All Publications

Data provided by UCSF Profiles, powered by CTSI at UCSF
  1. Vitiello GA, Hani L, Wang A, Porembka MR, Alterio R, Ju M, Turgeon MK, Lee RM, Russell MC, Kronenfeld J, Goel N, Datta J, Maker AV, Fernandez M, Richter H, Correa-Gallego C, Berman RS, Lee AY. Clinical Presentation Patterns and Survival Outcomes of Hispanic Patients with Gastric Cancer. J Surg Res. 2021 Aug 29; 268:606-615. View in PubMed
  2. Kronenfeld JP, Collier AL, Turgeon MK, Ju M, Alterio R, Wang A, Fernandez M, Porembka MR, Richter H, Lee AY, Russell MC, Merchant NB, Maker AV, Datta J. Attrition during neoadjuvant chemotherapy for gastric adenocarcinoma is associated with decreased survival: A United States Safety-Net Collaborative analysis. J Surg Oncol. 2021 Aug 11. View in PubMed
  3. Khan M, Maker AV, Jain S. The Evolution of Cancer Immunotherapy. Vaccines (Basel). 2021 Jun 08; 9(6). View in PubMed
  4. Turgeon MK, Lee RM, Keilson JM, Ju MR, Porembka MR, Alterio RE, Kronenfeld J, Datta J, Goel N, Wang A, Lee AY, Fernandez M, Richter H, Maker AV, Maithel SK, Russell MC. Is there a difference in utilization of a perioperative treatment approach for gastric cancer between safety net hospitals and tertiary referral centers? J Surg Oncol. 2021 Sep; 124(4):551-559. View in PubMed
  5. Carnahan LR, Jones L, Brewer KC, Watts EA, Peterson CE, Ferrans CE, Cipriano-Steffens T, Polite B, Maker AV, Chowdhery R, Molina Y, Rauscher GH. Race and Gender Differences in Awareness of Colorectal Cancer Screening Tests and Guidelines Among Recently Diagnosed Colon Cancer Patients in an Urban Setting. J Cancer Educ. 2021 06; 36(3):567-575. View in PubMed
  6. Maker AV, Al Rameni D, Prabhakar N. Combining On-Table Embolization with Immediate Resection to Safely Excise Giant Hepatic Hemangiomas. J Gastrointest Surg. 2021 06; 25(6):1651-1653. View in PubMed
  7. Fernandez MF, Qiao G, Tulla K, Prabhakar BS, Maker AV. Combination Immunotherapy With LIGHT and Interleukin-2 Increases CD8 Central Memory T-Cells In Vivo. J Surg Res. 2021 07; 263:44-52. View in PubMed
  8. Maker AV. ASO Author Reflections: How Can We Improve the Postoperative Experience for Our Pancreatic Cancer Patients? A Practical Technique to Optimize Pain Control After Major Abdominal Surgery. Ann Surg Oncol. 2021 Apr; 28(4):2296-2298. View in PubMed
  9. Kone LB, Kunda NM, Tran TB, Maker AV. Surgeon-Placed Continuous Wound Infusion Pain Catheters Markedly Decrease Narcotic Use and Improve Outcomes After Pancreatic Tumor Resection. Ann Surg Oncol. 2021 Apr; 28(4):2287-2295. View in PubMed
  10. Kone LB, Maker VK, Banulescu M, Maker AV. Epidural Analgesia Is Associated with Prolonged Length of Stay After Open HPB Surgery in Over 27,000 Patients. J Gastrointest Surg. 2021 07; 25(7):1716-1726. View in PubMed
  11. Kone LB, Torres C, Banulescu M, Maker VK, Maker AV. Perioperative Broad-spectrum Antibiotics are Associated With Decreased Surgical Site Infections Compared to 1st-3rd Generation Cephalosporins After Open Pancreaticoduodenectomy in Patients With Jaundice or a Biliary Stent. Ann Surg. 2020 Jul 24. View in PubMed
  12. Kone LB, Maker VK, Banulescu M, Maker AV. Should Drains Suck? A Propensity Score Analysis of Closed-Suction Versus Closed-Gravity Drainage After Pancreatectomy. J Gastrointest Surg. 2021 05; 25(5):1224-1232. View in PubMed
  13. Dai S, Lv Y, Xu W, Yang Y, Liu C, Dong X, Zhang H, Prabhakar BS, Maker AV, Seth P, Wang H. Oncolytic adenovirus encoding LIGHT (TNFSF14) inhibits tumor growth via activating anti-tumor immune responses in 4T1 mouse mammary tumor model in immune competent syngeneic mice. Cancer Gene Ther. 2020 12; 27(12):923-933. View in PubMed
  14. Bartlett DL, Howe JR, Chang G, Crago A, Hogg M, Karakousis G, Levine E, Maker A, Mamounas E, McGuire K, Merchant N, Shibata D, Sohn V, Solorzano C, Turaga K, White R, Yang A, Yoon S, Society of Surgical Oncology . Management of Cancer Surgery Cases During the COVID-19 Pandemic: Considerations. Ann Surg Oncol. 2020 Jun; 27(6):1717-1720. View in PubMed
  15. Kone LB, Maker VK, Banulescu M, Maker AV. A propensity score analysis of over 12,000 pancreaticojejunal anastomoses after pancreaticoduodenectomy: does technique impact the clinically relevant fistula rate? HPB (Oxford). 2020 10; 22(10):1394-1401. View in PubMed
  16. Saini S, Sripada L, Tulla K, Qiao G, Kunda N, Maker AV, Prabhakar BS. MADD silencing enhances anti-tumor activity of TRAIL in anaplastic thyroid cancer. Endocr Relat Cancer. 2019 06 01; 26(6):551-563. View in PubMed
  17. Maker AV, Hu V, Kadkol SS, Hong L, Brugge W, Winter J, Yeo CJ, Hackert T, Büchler M, Lawlor RT, Salvia R, Scarpa A, Bassi C, Green S. Cyst Fluid Biosignature to Predict Intraductal Papillary Mucinous Neoplasms of the Pancreas with High Malignant Potential. J Am Coll Surg. 2019 05; 228(5):721-729. View in PubMed
  18. Saini S, Sripada L, Tulla K, Kumar P, Yue F, Kunda N, Maker AV, Prabhakar BS. Loss of MADD expression inhibits cellular growth and metastasis in anaplastic thyroid cancer. Cell Death Dis. 2019 02 13; 10(2):145. View in PubMed
  19. Tran TB, Maker VK, Maker AV. Impact of Immunotherapy after Resection of Pancreatic Cancer. J Am Coll Surg. 2019 07; 229(1):19-27.e1. View in PubMed
  20. Saini S, Maker AV, Burman KD, Prabhakar BS. Molecular aberrations and signaling cascades implicated in the pathogenesis of anaplastic thyroid cancer. Biochim Biophys Acta Rev Cancer. 2019 12; 1872(2):188262. View in PubMed
  21. Mansour JC, Chavin K, Morris-Stiff G, Warner SG, Cardona K, Fong ZV, Maker A, Libutti SK, Warren R, St Hill C, Celinski S, Newell P, Ly QP, Howe J, Coburn N. Management of asymptomatic, well-differentiated PNETs: results of the Delphi consensus process of the Americas Hepato-Pancreato-Biliary Association. HPB (Oxford). 2019 05; 21(5):515-523. View in PubMed
  22. Maker AV, Tran TB, Coburn N, Fong ZV, Cardona K, Newell P, Morris-Stiff G, Chavin K, Mansour J, members of the AHPBA Research Committee Consensus Conference . Does attending a Delphi consensus conference impact surgeon attitudes? Survey results from the Americas HepatoPancreatoBiliary Association consensus conference on small asymptomatic pancreatic neuroendocrine tumors. HPB (Oxford). 2019 05; 21(5):524-530. View in PubMed
  23. Saini S, Tulla K, Maker AV, Burman KD, Prabhakar BS. Therapeutic advances in anaplastic thyroid cancer: a current perspective. Mol Cancer. 2018 10 23; 17(1):154. View in PubMed
  24. Maker AV. ASO Author Reflections: Improving Identification of Intraductal Papillary Mucinous Neoplasm Patients at Risk-Current Status and the Role of IPMN Molecular Biomarkers. Ann Surg Oncol. 2018 12; 25(Suppl 3):818-819. View in PubMed
  25. Marinelarena A, Bhattacharya P, Kumar P, Maker AV, Prabhakar BS. Identification of a Novel OX40L+ Dendritic Cell Subset That Selectively Expands Regulatory T cells. Sci Rep. 2018 10 08; 8(1):14940. View in PubMed
  26. Principe DR, Overgaard NH, Park AJ, Diaz AM, Torres C, McKinney R, Dorman MJ, Castellanos K, Schwind R, Dawson DW, Rana A, Maker A, Munshi HG, Rund LA, Grippo PJ, Schook LB. KRASG12D and TP53R167H Cooperate to Induce Pancreatic Ductal Adenocarcinoma in Sus scrofa Pigs. Sci Rep. 2018 08 22; 8(1):12548. View in PubMed
  27. Qin J, Kunda NM, Qiao G, Tulla K, Prabhakar BS, Maker AV. Vaccination With Mitoxantrone-Treated Primary Colon Cancer Cells Enhances Tumor-Infiltrating Lymphocytes and Clinical Responses in Colorectal Liver Metastases. J Surg Res. 2019 01; 233:57-64. View in PubMed
  28. Kumar P, Marinelarena A, Raghunathan D, Ragothaman VK, Saini S, Bhattacharya P, Fan J, Epstein AL, Maker AV, Prabhakar BS. Critical role of OX40 signaling in the TCR-independent phase of human and murine thymic Treg generation. Cell Mol Immunol. 2019 02; 16(2):138-153. View in PubMed
  29. Khoury RE, Kabir C, Maker VK, Banulescu M, Wasserman M, Maker AV. What is the Incidence of Malignancy in Resected Intraductal Papillary Mucinous Neoplasms? An Analysis of Over 100 US Institutions in a Single Year. Ann Surg Oncol. 2018 Jun; 25(6):1746-1751. View in PubMed
  30. El Khoury R, Kabir C, Maker VK, Banulescu M, Wasserman M, Maker AV. Do Drains Contribute to Pancreatic Fistulae? Analysis of over 5000 Pancreatectomy Patients. J Gastrointest Surg. 2018 06; 22(6):1007-1015. View in PubMed
  31. Tulla KA, Maker AV. Can we better predict the biologic behavior of incidental IPMN? A comprehensive analysis of molecular diagnostics and biomarkers in intraductal papillary mucinous neoplasms of the pancreas. Langenbecks Arch Surg. 2018 Mar; 403(2):151-194. View in PubMed
  32. Maker AV, Jarnagin WR. Port-Site Resection in the Surgical Management of Incidental Gallbladder Cancer: A Still Inconclusive Question: A Reply. Ann Surg Oncol. 2017 12; 24(Suppl 3):647-648. View in PubMed
  33. Jones LA, Ferrans CE, Polite BN, Brewer KC, Maker AV, Pauls HA, Rauscher GH. Examining racial disparities in colon cancer clinical delay in the Colon Cancer Patterns of Care in Chicago study. Ann Epidemiol. 2017 11; 27(11):731-738.e1. View in PubMed
  34. Schachtschneider KM, Schwind RM, Newson J, Kinachtchouk N, Rizko M, Mendoza-Elias N, Grippo P, Principe DR, Park A, Overgaard NH, Jungersen G, Garcia KD, Maker AV, Rund LA, Ozer H, Gaba RC, Schook LB. The Oncopig Cancer Model: An Innovative Large Animal Translational Oncology Platform. Front Oncol. 2017; 7:190. View in PubMed
  35. Alharshawi K, Marinelarena A, Kumar P, El-Sayed O, Bhattacharya P, Sun Z, Epstein AL, Maker AV, Prabhakar BS. PKC-ѳ is dispensable for OX40L-induced TCR-independent Treg proliferation but contributes by enabling IL-2 production from effector T-cells. Sci Rep. 2017 07 26; 7(1):6594. View in PubMed
  36. Maker AV, Sheikh R, Bhagia V, Diabetes Control and Complications Trial (DCCT) Research Group . Perioperative management of endocrine insufficiency after total pancreatectomy for neoplasia. Langenbecks Arch Surg. 2017 Sep; 402(6):873-883. View in PubMed
  37. Maker AV, Kunda N. A Technique to Define Extrahepatic Biliary Anatomy Using Robotic Near-Infrared Fluorescent Cholangiography. J Gastrointest Surg. 2017 Nov; 21(11):1961-1962. View in PubMed
  38. Grippo P, Maker AV. Targeting cancer with tumor-specific therapeutic strategies-metabolic reprogramming beyond the Warburg effect. Transl Cancer Res. 2017 May; 6(Suppl 3):S585-S586. View in PubMed
  39. Aung LHH, Li R, Prabhakar BS, Maker AV, Li P. Mitochondrial protein 18 (MTP18) plays a pro-apoptotic role in chemotherapy-induced gastric cancer cell apoptosis. Oncotarget. 2017 Aug 22; 8(34):56582-56597. View in PubMed
  40. Ejaz A, Casadaban L, Maker AV. Utilization and impact of adjuvant chemotherapy among patients with resected stage II colon cancer: a multi-institutional analysis. J Surg Res. 2017 07; 215:12-20. View in PubMed
  41. Qiao G, Qin J, Kunda N, Calata JF, Mahmud DL, Gann P, Fu YX, Rosenberg SA, Prabhakar BS, Maker AV. LIGHT Elevation Enhances Immune Eradication of Colon Cancer Metastases. Cancer Res. 2017 04 15; 77(8):1880-1891. View in PubMed
  42. Maker AV, Maker VK. Isolated Pancreatic Uncinate Duct IPMN. J Gastrointest Surg. 2017 04; 21(4):744-745. View in PubMed
  43. Qin J, Kunda N, Qiao G, Calata JF, Pardiwala K, Prabhakar BS, Maker AV. Colon cancer cell treatment with rose bengal generates a protective immune response via immunogenic cell death. Cell Death Dis. 2017 02 02; 8(2):e2584. View in PubMed
  44. Casadaban L, Maker AV. Can Colon Cancer Recurrence and Metastases Be Determined After Surgical Resection Using a Gene Expression Signature? J Clin Oncol. 2017 04 20; 35(12):1372-1373. View in PubMed
  45. Jamieson NB, Maker AV. Gene-expression profiling to predict responsiveness to immunotherapy. Cancer Gene Ther. 2017 Mar; 24(3):134-140. View in PubMed
  46. Carr RM, Qiao G, Qin J, Jayaraman S, Prabhakar BS, Maker AV. Targeting the metabolic pathway of human colon cancer overcomes resistance to TRAIL-induced apoptosis. Cell Death Discov. 2016; 2:16067. View in PubMed
  47. Casadaban L, Rauscher G, Aklilu M, Villenes D, Freels S, Maker AV. Adjuvant chemotherapy is associated with improved survival in patients with stage II colon cancer. Cancer. 2016 Nov 15; 122(21):3277-3287. View in PubMed
  48. Maker AV, Maker VK. Techniques to perform robotic left adrenalectomy in the obese patient. Surg Endosc. 2017 02; 31(2):950. View in PubMed
  49. Maker AV, August C, Maker VK, Weisenberg E. Hepatectomy After Yttrium-90 (Y90) Radioembolization-Induced Liver Fibrosis. J Gastrointest Surg. 2016 Apr; 20(4):869-70. View in PubMed
  50. Maker AV, Valbuena V, Maker VK. A Minimally Invasive Technique to Obtain Optimal Tumor Margins in Anatomically Confined Locations Using a Contoured Stapler. Ann Surg Oncol. 2015 Dec; 22 Suppl 3:S340. View in PubMed
  51. Maker AV. Precise identification of immunotherapeutic targets for solid malignancies using clues within the tumor microenvironment-Evidence to turn on the LIGHT. Oncoimmunology. 2016; 5(1):e1069937. View in PubMed
  52. Maker AV, Prabhakar B, Pardiwala K. The Potential of Intralesional Rose Bengal to Stimulate T-Cell Mediated Anti-Tumor Responses. J Clin Cell Immunol. 2015 Aug; 6(4). View in PubMed
  53. Maker AV, Carr R. Techniques to perform a laparoscopic right adrenalectomy for metastases abutting the liver, renal vein, and posterior vena cava. Surg Endosc. 2016 Mar; 30(3):1226. View in PubMed
  54. Bhagwandin SB, Weisenberg ES, Ozer H, Maker AV. Symptomatic Massive Splenomegaly in Persistent Polyclonal B-cell Lymphocytosis Requiring Splenectomy. Open J Clin Med Case Rep. 2015; 1(3). View in PubMed
  55. Maker AV. Tailoring GIST therapy—biology is still king. JAMA Surg. 2015 Apr; 150(4):306-7. View in PubMed
  56. Kopanja D, Pandey A, Kiefer M, Wang Z, Chandan N, Carr JR, Franks R, Yu DY, Guzman G, Maker A, Raychaudhuri P. Essential roles of FoxM1 in Ras-induced liver cancer progression and in cancer cells with stem cell features. J Hepatol. 2015 Aug; 63(2):429-36. View in PubMed
  57. August C, Maker AV, Weisenberg E. Simultaneous Occurrence of Glandular and Neuroendocrine Components in Lymph Node Metastasis of Gastric MANEC. Int J Surg Pathol. 2015 Aug; 23(5):375-6. View in PubMed
  58. Maker AV, Iteld L. Closure of Melanoma Defects on the Sole of the Foot Using Glaborous Skin: The End of the Flap? Ann Surg Oncol. 2015 Nov; 22(12):4081-2. View in PubMed
  59. Pardiwala KH, Maker AV. Operative management of portal annular pancreas during pancreaticoduodenectomy. Surgery. 2016 Mar; 159(3):972-4. View in PubMed
  60. Maker AV, Ito H, Mo Q, Weisenberg E, Qin LX, Turcotte S, Maithel S, Shia J, Blumgart L, Fong Y, Jarnagin WR, DeMatteo RP, D'Angelica MI. Genetic evidence that intratumoral T-cell proliferation and activation are associated with recurrence and survival in patients with resected colorectal liver metastases. Cancer Immunol Res. 2015 Apr; 3(4):380-8. View in PubMed
  61. Maker AV, Carrara S, Jamieson NB, Pelaez-Luna M, Lennon AM, Dal Molin M, Scarpa A, Frulloni L, Brugge WR. Cyst fluid biomarkers for intraductal papillary mucinous neoplasms of the pancreas: a critical review from the international expert meeting on pancreatic branch-duct-intraductal papillary mucinous neoplasms. J Am Coll Surg. 2015 Feb; 220(2):243-53. View in PubMed
  62. Kitano M, Maker AV, Lanier BJ, Danforth DN, Kammula US. Appendicitis secondary to metastatic melanoma: review of the National Institutes of Health experience. JAMA Surg. 2014 Jul; 149(7):735-8. View in PubMed
  63. Valladolid G, Weisenberg E, Sundaresan R, Maker AV. Calcifying fibrous tumor of the small intestine associated with Castleman-like lymphadenopathy. J Gastrointest Surg. 2014 Jun; 18(6):1205-8. View in PubMed
  64. Choi JJ, Sinada-Bottros L, Maker AV, Weisenberg E. Dedifferentiated gastrointestinal stromal tumor arising de novo from the small intestine. Pathol Res Pract. 2014 Apr; 210(4):264-6. View in PubMed
  65. Li LC, Wang Y, Carr R, Haddad CS, Li Z, Qian L, Oberholzer J, Maker AV, Wang Q, Prabhakar BS. IG20/MADD plays a critical role in glucose-induced insulin secretion. Diabetes. 2014 May; 63(5):1612-23. View in PubMed
  66. Ito H, Mo Q, Qin LX, Viale A, Maithel SK, Maker AV, Shia J, Kingham P, Allen P, DeMatteo RP, Fong Y, Jarnagin WR, D'Angelica M. Gene expression profiles accurately predict outcome following liver resection in patients with metastatic colorectal cancer. PLoS One. 2013; 8(12):e81680. View in PubMed
  67. Calata JF, Sukerkar AN, August CZ, Maker AV. Benign adrenal hemangiomas may mimic metastases on PET. Clin Nucl Med. 2013 Nov; 38(11):888-90. View in PubMed
  68. Kaminski JP, Maker VK, Maker AV. Management of patients with abdominal malignancy after remote jejunoileal bypass: surgical considerations decades later. J Am Coll Surg. 2013 Nov; 217(5):929-39. View in PubMed
  69. Maker AV. A technique for laparoendoscopic resection of posterior fundic gastric GISTs without need for a gastrotomy. Ann Surg Oncol. 2013 Dec; 20(13):4238. View in PubMed
  70. Avraham JB, Villines D, Maker VK, August C, Maker AV. Survival after resection of cutaneous adnexal carcinomas with eccrine differentiation: risk factors and trends in outcomes. J Surg Oncol. 2013 Jul; 108(1):57-62. View in PubMed
  71. Qin JZ, Upadhyay V, Prabhakar B, Maker AV. Shedding LIGHT (TNFSF14) on the tumor microenvironment of colorectal cancer liver metastases. J Transl Med. 2013 Mar 20; 11:70. View in PubMed
  72. Turner A, Li LC, Pilli T, Qian L, Wiley EL, Setty S, Christov K, Ganesh L, Maker AV, Li P, Kanteti P, Das Gupta TK, Prabhakar BS. MADD knock-down enhances doxorubicin and TRAIL induced apoptosis in breast cancer cells. PLoS One. 2013; 8(2):e56817. View in PubMed
  73. Valladolid G, Adams LL, Weisenberg E, Maker VK, Maker AV. Primary hepatic lymphoma presenting as an isolated solitary hepatic cyst. J Clin Oncol. 2013 Jan 10; 31(2):e21-3. View in PubMed
  74. Maker VK, Zahedi MM, Villines D, Maker AV. Can we predict which residents are going to pass/fail the oral boards? J Surg Educ. 2012 Nov-Dec; 69(6):705-13. View in PubMed
  75. Katz SC, Bamboat ZM, Maker AV, Shia J, Pillarisetty VG, Yopp AC, Hedvat CV, Gonen M, Jarnagin WR, Fong Y, D'Angelica MI, DeMatteo RP. Regulatory T cell infiltration predicts outcome following resection of colorectal cancer liver metastases. Ann Surg Oncol. 2013 Mar; 20(3):946-55. View in PubMed
  76. Maker AV, Maker VK. Malignant masquerade of xanthogranulomatous cholecystitis on intraoperative ultrasound of the liver. J Surg Oncol. 2012 Sep 15; 106(4):525-6. View in PubMed
  77. Maker AV, Jamal W, Gayet B. Video: totally laparoscopic left lateral segmentectomy for hepatic malignancies: a modified technique. J Gastrointest Surg. 2011 Sep; 15(9):1650. View in PubMed
  78. Maker AV, Butte JM, Oxenberg J, Kuk D, Gonen M, Fong Y, Dematteo RP, D'Angelica MI, Allen PJ, Jarnagin WR. Is port site resection necessary in the surgical management of gallbladder cancer? Ann Surg Oncol. 2012 Feb; 19(2):409-17. View in PubMed
  79. Li LC, Jayaram S, Ganesh L, Qian L, Rotmensch J, Maker AV, Prabhakar BS. Knockdown of MADD and c-FLIP overcomes resistance to TRAIL-induced apoptosis in ovarian cancer cells. Am J Obstet Gynecol. 2011 Oct; 205(4):362.e12-25. View in PubMed
  80. Maker AV, Katabi N, Qin LX, Klimstra DS, Schattner M, Brennan MF, Jarnagin WR, Allen PJ. Cyst fluid interleukin-1beta (IL1beta) levels predict the risk of carcinoma in intraductal papillary mucinous neoplasms of the pancreas. Clin Cancer Res. 2011 Mar 15; 17(6):1502-8. View in PubMed
  81. Maker AV, Katabi N, Gonen M, DeMatteo RP, D'Angelica MI, Fong Y, Jarnagin WR, Brennan MF, Allen PJ. Pancreatic cyst fluid and serum mucin levels predict dysplasia in intraductal papillary mucinous neoplasms of the pancreas. Ann Surg Oncol. 2011 Jan; 18(1):199-206. View in PubMed
  82. Rudloff U, Maker AV, Brennan MF, Allen PJ. Randomized clinical trials in pancreatic adenocarcinoma. Surg Oncol Clin N Am. 2010 Jan; 19(1):115-50. View in PubMed
  83. Maker AV, Warth JA, Zinner MJ. Novel presentation of a familial pancreatic cancer syndrome. J Gastrointest Surg. 2009 Jun; 13(6):1151-4. View in PubMed
  84. Maker AV, Lee LS, Raut CP, Clancy TE, Swanson RS. Cytology from pancreatic cysts has marginal utility in surgical decision-making. Ann Surg Oncol. 2008 Nov; 15(11):3187-92. View in PubMed
  85. Maker AV, Yang JC, Sherry RM, Topalian SL, Kammula US, Royal RE, Hughes M, Yellin MJ, Haworth LR, Levy C, Allen T, Mavroukakis SA, Attia P, Rosenberg SA. Intrapatient dose escalation of anti-CTLA-4 antibody in patients with metastatic melanoma. J Immunother. 2006 Jul-Aug; 29(4):455-63. View in PubMed
  86. Attia P, Powell DJ, Maker AV, Kreitman RJ, Pastan I, Rosenberg SA. Selective elimination of human regulatory T lymphocytes in vitro with the recombinant immunotoxin LMB-2. J Immunother. 2006 Mar-Apr; 29(2):208-14. View in PubMed
  87. Maker AV, Attia P, Rosenberg SA. Analysis of the cellular mechanism of antitumor responses and autoimmunity in patients treated with CTLA-4 blockade. J Immunol. 2005 Dec 01; 175(11):7746-54. View in PubMed
  88. Hanna RF, Ward TJ, Chow DS, Lagana SM, Moreira RK, Emond JC, Weintraub JL, Prince MR. An evaluation of the sensitivity of MRI at detecting hepatocellular carcinoma in cirrhotic patients utilizing an explant reference standard. Clin Imaging. 2014 Sep-Oct; 38(5):693-7. View in PubMed
  89. Attia P, Maker AV, Haworth LR, Rogers-Freezer L, Rosenberg SA. Inability of a fusion protein of IL-2 and diphtheria toxin (Denileukin Diftitox, DAB389IL-2, ONTAK) to eliminate regulatory T lymphocytes in patients with melanoma. J Immunother. 2005 Nov-Dec; 28(6):582-92. View in PubMed
  90. Maker AV, Phan GQ, Attia P, Yang JC, Sherry RM, Topalian SL, Kammula US, Royal RE, Haworth LR, Levy C, Kleiner D, Mavroukakis SA, Yellin M, Rosenberg SA. Tumor regression and autoimmunity in patients treated with cytotoxic T lymphocyte-associated antigen 4 blockade and interleukin 2: a phase I/II study. Ann Surg Oncol. 2005 Dec; 12(12):1005-16. View in PubMed
  91. Hanna RF, Ward TJ, Chow DS, Lagana SM, Moreira RK, Emond JC, Weintraub JL, Prince MR. An evaluation of the sensitivity of MRI at detecting hepatocellular carcinoma in cirrhotic patients utilizing an explant reference standard. Clin Imaging. 2014 Sep-Oct; 38(5):693-7. View in PubMed
  92. Attia P, Phan GQ, Maker AV, Robinson MR, Quezado MM, Yang JC, Sherry RM, Topalian SL, Kammula US, Royal RE, Restifo NP, Haworth LR, Levy C, Mavroukakis SA, Nichol G, Yellin MJ, Rosenberg SA. Autoimmunity correlates with tumor regression in patients with metastatic melanoma treated with anti-cytotoxic T-lymphocyte antigen-4. J Clin Oncol. 2005 Sep 01; 23(25):6043-53. View in PubMed
  93. Maker AV, Orgill DP. Rapid acute amiodarone-induced hepatotoxicity in a burn patient. J Burn Care Rehabil. 2005 Jul-Aug; 26(4):341-3. View in PubMed
  94. Eisenberg ML, Maker AV, Slezak LA, Nathan JD, Sritharan KC, Jena BP, Geibel JP, Andersen DK. Insulin receptor (IR) and glucose transporter 2 (GLUT2) proteins form a complex on the rat hepatocyte membrane. Cell Physiol Biochem. 2005; 15(1-4):51-8. View in PubMed